| 1 |
Predicting the Number of GHB-Related Toxicologic Admissions Using Google Trends Data |
|
|
| Máté Kapitány-Fövény, Tamás Ferenci, Zsolt Demetrovics, Mihály Sulyok |
|
| International Journal of Mental Health and Addiction. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas |
|
|
| Filipa Raposo Pereira,Minni T. B. McMaster,YvonD. A. T. de Vries,Wim van den Brink,Guido A. van Wingen |
|
| Substance Use & Misuse. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Monitoring of altered amino acid metabolic pattern in rat urine following intraperitoneal injection with ?-hydroxybutyric acid |
|
|
| Chan Seo,Myungjin Na,Jiyeun Jang,Meejung Park,Boyeon Choi,Sooyeun Lee,Man-Jeong Paik |
|
| Metabolomics. 2018; 14(9) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review |
|
|
| Rama M. Kamal, Martijn S. van Noorden, Ernst Franzek, Boukje A.G. Dijkstra, Anton J.M. Loonen, Cornelius A.J. De Jong |
|
| Neuropsychobiology. 2016; 73(2): 65 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Pharmacological Treatment in ?-Hydroxybutyrate (GHB) and ?-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention |
|
|
| Rama M. Kamal,Martijn S. van Noorden,Wim Wannet,Harmen Beurmanjer,Boukje A. G. Dijkstra,Arnt Schellekens |
|
| CNS Drugs. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Recreational drug use and human aggressive behavior: A comprehensive review since 2003 |
|
|
| Monica F. Tomlinson,Matthew Brown,Peter N.S. Hoaken |
|
| Aggression and Violent Behavior. 2016; 27: 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1 |
|
|
| Samar Alzeer,Elizabeth M. Ellis |
|
| Biochemical Pharmacology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators |
|
|
| Malgorzata Filip,Malgorzata Frankowska,Anna Sadakierska-Chudy,Agata Suder,Lukasz Szumiec,Pawel Mierzejewski,Przemyslaw Bienkowski,Edmund Przegalinski,John F. Cryan |
|
| Neuropharmacology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
